587

THE MOLECULAR MECHANISMS OF HYPOXIA-INDUCED EPITHELIAL DAMAGE IN HUMAN FETAL INTESTINAL ORGANOIDS

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

This session will provide the latest developmental research in human-derived organoids.
Background: Colon epithelial mitochondrial (MT) dysfunction is implicated in the pathogenesis of pediatric UC. Patient-derived organoids recapitulate several complexities of the parent tissue, but it is unknown if they can model the mitochondrial functional impairments observed in the UC epithelium. The aim of this study is to identify functional metabolic derangements unique to the pediatric UC epithelium using patient-derived colon organoids (colonoids) as a model of human UC.

Methods: We generated colonoids from rectal biopsies obtained from pediatric patients with endoscopically active and inactive UC, and non-IBD controls [n=4/grp, median age 14.5 yrs]. Cryopreserved colonoids were thawed, passaged, and differentiated for 3 days. We analyzed the bioenergetics of colonoids (in quadruplicate) in real-time through Seahorse Analyzer MT stress testing. We used gene expression analysis, imaging, spectrometric, and flow cytometric methods to assess MT membrane potential (MMP), MT-reactive oxygen species (ROS) production, MT-mass, and MT-uncoupling proteins.

Results: At baseline, colonoids from active UC patients consumed more oxygen than those from non-IBD controls (P=.021), but produced a similar amount of ATP. Accordingly, we found an 85% increase in proton leak and lower MMP (assessed by JC-1 uptake) in active UC compared to non-IBD colonoids (P=.015) (Figure 1). Moreover, MT-ROS production was higher in active UC compared to non-IBD colonoids. In line with the observed higher proton leak in active UC, we found a significantly increased gene and protein expression of the MT respiratory chain uncoupling protein Ucp2 in active UC compared to non-IBD colonoids (P=.030 and .024, respectively, Figure 2). We validated the observed elevated Ucp2 in active UC through the analysis of rectal bulk RNA-seq data from the PROTECT Pediatric UC inception cohort (GSE109142). In the stem cell state before differentiation, MT-mass (normalized to 7-AAD- colonoid single cells) was similar among all colonoid groups. After differentiation, active UC colonoids exhibited higher mitochondrial mass than non-IBD controls (P=.019). Overall, colonoids from inactive UC patients showed similar metabolic characteristics to non-IBD controls.

Conclusion: Colonoids derived from active pediatric UC patients demonstrate inefficient MT bioenergetics marked by higher proton leak and the requirement of more oxygen to generate ATP compared to those from non-IBD patients. Such MT inefficiency may be caused by observed higher expression of uncoupling protein or increased ROS generation in UC colonoids. These data demonstrate that UC epithelial MT functional impairment can be modeled in patient-derived colonoids and support advancing colonoids as a preclinical human model for testing therapies against such metabolic dysfunction.
<b>Figure 1:</b> Impaired Mitochondrial metabolism in Active UC (UC) colonoids compared to non-IBD Control colonoids (C). (a) A sample well ready for Seahorse MitoStress Test after 3 d differentiation. Scale bar= 200 μm. (b) Bioenergetic profile of active UC vs C colonoids. (c) Increased basal respiration and (d) Elevated proton leak in active UC vs C colonoids.

Figure 1: Impaired Mitochondrial metabolism in Active UC (UC) colonoids compared to non-IBD Control colonoids (C). (a) A sample well ready for Seahorse MitoStress Test after 3 d differentiation. Scale bar= 200 μm. (b) Bioenergetic profile of active UC vs C colonoids. (c) Increased basal respiration and (d) Elevated proton leak in active UC vs C colonoids.

<b>Figure 2:</b> Elevated uncoupling protein 2 (UCP2) expression in colonoids from active UC vs non-IBD controls. (a) Rectal bulk RNA-seq data from the PROTECT Pediatric UC inception cohort study showed a significant upregulation of Ucp2 gene in UC rectal tissues vs non-IBD controls. n=20 for C, 206 for UC. P < 0.0001 from the Mann-Whitney test. (b) Ucp2 mRNA is more abundant in UC colonoids compared to control. (c) Representative immunofluorescent images of OCT-embedded colonoids stained with DAPI (nuclei), Phalloidin (F-actin), mitochondrial marker antibody (Cox4), and Ucp2 antibody. Arrows show co-expression of Cox4+Ucp2+ (yellow marks) in the merged image. Scale bar = 50 μm. UCP2 expression was quantified in 4 high-power fields per sample and expressed per nucleated cells. n=4 patients/grp. The line within the boxplot represents the median, + represents the mean, and the symbol above and below the whiskers represents the outliers that are either greater than the 95th or less than the 5th percentile.

Figure 2: Elevated uncoupling protein 2 (UCP2) expression in colonoids from active UC vs non-IBD controls. (a) Rectal bulk RNA-seq data from the PROTECT Pediatric UC inception cohort study showed a significant upregulation of Ucp2 gene in UC rectal tissues vs non-IBD controls. n=20 for C, 206 for UC. P < 0.0001 from the Mann-Whitney test. (b) Ucp2 mRNA is more abundant in UC colonoids compared to control. (c) Representative immunofluorescent images of OCT-embedded colonoids stained with DAPI (nuclei), Phalloidin (F-actin), mitochondrial marker antibody (Cox4), and Ucp2 antibody. Arrows show co-expression of Cox4+Ucp2+ (yellow marks) in the merged image. Scale bar = 50 μm. UCP2 expression was quantified in 4 high-power fields per sample and expressed per nucleated cells. n=4 patients/grp. The line within the boxplot represents the median, + represents the mean, and the symbol above and below the whiskers represents the outliers that are either greater than the 95th or less than the 5th percentile.

Background: Preterm birth is a risk factor for Necrotizing enterocolitis (NEC), a complex intestinal complication that occurs in 2-13% of preterm neonates. There is limited understanding of disease pathology and treatment options. Hypoxic events thought to be important contributors to NEC. We aim to set up an in vitro model, that can be used to improve our understanding of hypoxia-induced molecular mechanisms of intestinal barrier failure in early life intestinal disease.

Methods: We determined hypoxia-induced molecular and functional responses in 3D human fetal intestinal organoids. Organoids were derived from human fetal intestinal tissue (18-21 weeks of gestation). Organoids were exposed to hypoxic (1% O2) and normoxic (21% O2) culture conditions for time periods up to 68 hours. Hypoxia-inducible factor signaling downstream target glucose transporter-1 (GLUT1) was used as marker for hypoxia-induced epithelial damage in organoids and validated in NEC tissue. Morphological changes of organoids induced by hypoxia were assessed by hematoxylin and eosin staining on paraffin sections. Epithelial permeability was determined by FITC-dextran 4 kDa (FD4) flux, monitored by mean fluorescence intensity ratios of lumen versus basolateral comportments. Differentially expressed genes were assessed by RNA-seq after 6 and 24 hours of hypoxia compared to normoxia. Apoptosis analysis were performed after hypoxia exposure. AnnexinV+ cell populations were determined by flow cytometry, and propidium iodide (PI) positive organoids were observed by fluorescence microscopy.

Results: Immunofluorescence microscopy showed 4.4 and 3.0 fold increase of relative GLUT1 expression after 6 and 24 hours of hypoxia exposure compared normoxia in organoids (n=2 donors). Increased levels of GLUT1 were observed along intestinal damaged areas in NEC tissue (n=2). Ruffled membranes, observed at 24 hours after hypoxia, indicated hypoxia-induced morphological changes in organoids. Compared to normoxia, hypoxia lead to increased FD4 flux at 6 and 24 hour time points (11% (p=0.09) and 59% (p=0.025) respectively, n=3). Amongst others, RNA-seq gene set enrichment analysis identified significantly enriched pathways (padj<0.05) related to hypoxia (incl. GLUT1), and apoptosis at 6 (n=5) and 24 hours (n=6) versus normoxia. AnnexinV analysis of post-hypoxia and control cell suspensions confirmed increased apoptosis after 24 and 68-72 hours (16% (p=0.07) and 27% (p=0.006) respectively; n=5). Also hypoxia-induced increased PI intensity levels were observed by microscopy.

Conclusions: The current results suggest that our human intestinal organoid-hypoxia model may be used as a proxy for hypoxia-induced intestinal damage in early life intestinal diseases. Our model could support identification of potential therapeutic targets that can be evaluated at epithelial functional and molecular level.

Tracks

Related Products

Thumbnail for TRYPTOPHAN METABOLITE CHANGES WITH DIET-INDUCED REMISSION IN PEDIATRIC CROHN’S DISEASE
TRYPTOPHAN METABOLITE CHANGES WITH DIET-INDUCED REMISSION IN PEDIATRIC CROHN’S DISEASE
BACKGROUND: Our team (Xiong et al. 2021) recently developed an infliximab population pharmacokinetic (popPK) model in children and young adults with Crohn’s disease (CD). We found that prediction accuracy improved when all five covariates of drug clearance were included…
Thumbnail for AGA Aryl Hydrocarbon Receptor in Gastrointestinal Disease
AGA Aryl Hydrocarbon Receptor in Gastrointestinal Disease
The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components…
Thumbnail for THE ROLE OF ARYL HYDROCARBON RECEPTOR SIGNALING IN POSTOPERATIVE INTESTINAL HEALING
THE ROLE OF ARYL HYDROCARBON RECEPTOR SIGNALING IN POSTOPERATIVE INTESTINAL HEALING
The mammalian tissues express a huge number of circular RNAs (circRNAs) with an active role in gene regulation. circRNAs are covalently closed at the 5’ and 3’ ends, unusually stable, and are highly distributed in the cytoplasm…
Thumbnail for ROLE OF GUT MICROBIOTA DERIVED AHR LIGANDS IN THE DEVELOPMENT OF INTESTINAL FAILURE IN INFANTS
ROLE OF GUT MICROBIOTA DERIVED AHR LIGANDS IN THE DEVELOPMENT OF INTESTINAL FAILURE IN INFANTS
The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components…